115 related articles for article (PubMed ID: 9827619)
1. Effect of dystonia and botulinum toxin treatment on health-related quality of life.
Gudex CM; Hawthorne MR; Butler AG; Duffey P
Mov Disord; 1998 Nov; 13(6):941-6. PubMed ID: 9827619
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30).
Tan EK; Fook-Chong S; Lum SY; Lim E
J Neurol Sci; 2004 Apr; 219(1-2):151-5. PubMed ID: 15050451
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
Whitaker J; Butler A; Semlyen JK; Barnes MP
Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
[TBL] [Abstract][Full Text] [Related]
4. [A survey about the accessibility to botulinum toxin therapy for dystonia].
Mezaki T; Hayashi A; Nakase H; Hasegawa K
No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446
[TBL] [Abstract][Full Text] [Related]
5. Measuring patient benefit from botulinum toxin in the treatment of dystonia. Feasibility of cost-utility analysis.
Gudex CM; Hawthorne MR; Butler AG; Duffey PO
Pharmacoeconomics; 1997 Dec; 12(6):675-84. PubMed ID: 10175979
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in focal, segmental, and generalized dystonia.
Page D; Butler A; Jahanshahi M
Mov Disord; 2007 Feb; 22(3):341-7. PubMed ID: 17216640
[TBL] [Abstract][Full Text] [Related]
7. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
[TBL] [Abstract][Full Text] [Related]
8. The validation of the disease-specific questionnaire for health-related quality of life in Thai patients with hemifacial spasm.
Setthawatcharawanich S; Aui-aree N; Limapichart K; Satirapunya P; Phabphal K
J Med Assoc Thai; 2008 Nov; 91(11):1691-7. PubMed ID: 19127791
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
[TBL] [Abstract][Full Text] [Related]
11. Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.
Milstone A; Patsimas J; Farzan D; Castaldo R; Singh H; Feurer I; Harnett J; Luke DR;
Clin Ther; 2005 Jun; 27(6):926-39. PubMed ID: 16117993
[TBL] [Abstract][Full Text] [Related]
12. Immediate response to botulinum toxin injections in patients with fixed dystonia.
Edwards MJ; Bhatia KP; Cordivari C
Mov Disord; 2011 Apr; 26(5):917-8. PubMed ID: 21394784
[No Abstract] [Full Text] [Related]
13. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
Tan AK
Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
[TBL] [Abstract][Full Text] [Related]
14. Jaw-opening dystonia: Quality of life after botulinum toxin injections.
Charous SJ; Comella CL; Fan W
Ear Nose Throat J; 2011 Feb; 90(2):E9. PubMed ID: 21328222
[TBL] [Abstract][Full Text] [Related]
15. The current use of botulinum toxin.
Mahant N; Clouston PD; Lorentz IT
J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
[TBL] [Abstract][Full Text] [Related]
16. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R;
Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312
[TBL] [Abstract][Full Text] [Related]
17. Nonpharmacologic effects of botulinum toxin on the life quality of patients with spasmodic dysphonia.
Anari S; Carding PN; Hawthorne MR; Deakin J; Drinnan MJ
Laryngoscope; 2007 Oct; 117(10):1888-92. PubMed ID: 17690610
[TBL] [Abstract][Full Text] [Related]
18. Medical therapy and botulinum toxin in dystonia.
Jankovic J
Adv Neurol; 1998; 78():169-83. PubMed ID: 9750914
[No Abstract] [Full Text] [Related]
19. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
O'Brien CF
Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231
[No Abstract] [Full Text] [Related]
20. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.
Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W;
J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]